BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 12861106)

  • 21. Drug-induced torsades de pointes in patients aged 80 years or more.
    Paran Y; Mashav N; Henis O; Swartzon M; Arbel Y; Justo D
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):260-5. PubMed ID: 18676301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.
    Calderone V; Testai L; Martinotti E; Del Tacca M; Breschi MC
    J Pharm Pharmacol; 2005 Feb; 57(2):151-61. PubMed ID: 15720777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
    Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports.
    Justo D; Zeltser D
    Mycoses; 2006 Nov; 49(6):463-70. PubMed ID: 17022762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.
    Faigel DO; Metz DC; Kochman ML
    Am J Gastroenterol; 1995 May; 90(5):822-4. PubMed ID: 7733096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced q-T prolongation.
    Kao LW; Furbee RB
    Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Torsades de pointe with spiramycine and metiquazine therapy. Apropos of a case].
    Verdun F; Mansourati J; Jobic Y; Bouquin V; Munier S; Guillo P; Pagès Y; Boschat J; Blanc JJ
    Arch Mal Coeur Vaiss; 1997 Jan; 90(1):103-6. PubMed ID: 9137721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.
    Antonelli D; Atar S; Freedberg NA; Rosenfeld T
    Isr Med Assoc J; 2005 Mar; 7(3):163-5. PubMed ID: 15792261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing predictors of drug-induced torsade de pointes.
    Belardinelli L; Antzelevitch C; Vos MA
    Trends Pharmacol Sci; 2003 Dec; 24(12):619-25. PubMed ID: 14654302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
    Tsai WC; Tsai LM; Chen JH
    J Formos Med Assoc; 1997 Feb; 96(2):144-6. PubMed ID: 9071844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Why is QT interval interesting?].
    Elming H; Sonne J; Lublin HK
    Ugeskr Laeger; 2002 Feb; 164(6):750-4. PubMed ID: 11851179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moxifloxacin-induced torsades de pointes.
    Sherazi S; DiSalle M; Daubert JP; Shah AH
    Cardiol J; 2008; 15(1):71-3. PubMed ID: 18651388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Torsade de pointes--a cause of Morgagni-Adam-Stokes attacks in patients with complete atrioventricular block].
    Antonelli D; Rozner E; Freedberg NA; Turgeman Y
    Harefuah; 2008 Mar; 147(3):204-6, 279. PubMed ID: 18488859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical study of amiodarone-associated torsade de pointes in Chinese people.
    Geng DF; Jin DM; Wang JF; Luo YJ; Wu W
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):712-8. PubMed ID: 16884506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.